Tanvex BioPharma Inc (6541) — Financial Flexibility Index
Tanvex BioPharma Inc (6541) has a Financial Flexibility Index of 0.13x as of December 2025. Free cash flow of NT$300.53 Million (operating CF NT$-166.26 Million minus capex NT$466.79 Million) represents 0% of total liabilities (NT$2.27 Billion). Also explore Tanvex BioPharma Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tanvex BioPharma Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tanvex BioPharma Inc across 13 annual periods. Check Tanvex BioPharma Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tanvex BioPharma Inc (2013–2025)
Year-by-year free cash flow to debt coverage for Tanvex BioPharma Inc. For the full company profile including market capitalisation, see 6541 market cap overview.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | NT$-335.24 Million | NT$-1.01 Billion | NT$2.27 Billion | ▲ +73.8% |
| 2024 | -0.56x | NT$-1.04 Billion | NT$-1.15 Billion | NT$1.84 Billion | ▲ +19.5% |
| 2023 | -0.70x | NT$-1.36 Billion | NT$-1.43 Billion | NT$1.94 Billion | ▼ -15.0% |
| 2022 | -0.61x | NT$-1.24 Billion | NT$-1.33 Billion | NT$2.03 Billion | ▲ +13.7% |
| 2021 | -0.71x | NT$-1.36 Billion | NT$-1.39 Billion | NT$1.92 Billion | ▲ +28.0% |
| 2020 | -0.98x | NT$-1.72 Billion | NT$-1.79 Billion | NT$1.75 Billion | ▲ +70.5% |
| 2019 | -3.33x | NT$-1.81 Billion | NT$-1.90 Billion | NT$542.12 Million | ▲ +41.3% |
| 2018 | -5.67x | NT$-1.50 Billion | NT$-1.61 Billion | NT$263.92 Million | ▼ -15.9% |
| 2017 | -4.90x | NT$-1.10 Billion | NT$-1.21 Billion | NT$223.78 Million | ▼ -150.5% |
| 2016 | -1.95x | NT$-584.86 Million | NT$-833.43 Million | NT$299.25 Million | ▲ +23.6% |
| 2015 | -2.56x | NT$-310.73 Million | NT$-684.20 Million | NT$121.41 Million | ▲ +40.1% |
| 2014 | -4.27x | NT$-278.11 Million | NT$-434.17 Million | NT$65.09 Million | ▼ -85.7% |
| 2013 | -2.30x | NT$-192.38 Million | NT$-239.86 Million | NT$83.63 Million | — |